Protocol for treatment and research of acute lymphoblastic leukaemia of childhood of the Dutch Childhood Oncology Group (SNWLK/DCOG ALL-9).

Protocol for treatment and research of acute lymphoblastic leukaemia of childhood of the Dutch Childhood Oncology Group (formerly Stichting Nederlandse Werkgroep Leukemie bij Kinderen, SNWLK).

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON21934

Enrollment

918

Registered

2005-08-24

Start date

1997-01-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute lymphoblastic leukaemia of childhood.

Interventions

Stratification into standard risk and high risk.

Eligibility

Inclusion criteria

Inclusion criteria: All children with acute lymphoblastic leukaemia from 1 year (365 days) until 18 years of age, excluding mature B-cell ALL.

Exclusion criteria

Exclusion criteria: 1. Mature B-cell ALL; 2. Relapsed ALL; 3. Secondary ALL; 4. Pretreatment with corticostroids or cytostatic drugs in the 4 weeks preceding diagnosis; 5. Patient of whom essential diagnostic tests are missing; 6. Patients in whom essential parts of therapy were not given.

Design outcomes

Primary

Measure	Time frame
Survival.	—

Secondary

Measure	Time frame
Event free survival.	—

Contacts

Public ContactJ.G. Ridder-Sluiter, de

Stichting Kinder Oncologie (SKION), Leyweg 299

hderidder@skion.nl+31 (0)70 3674545

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)